Drug Profile
Peginterferon alfa-2b biosimilar - Amega Biotech
Alternative Names: Peginterferon alpha-2b biosimilar - Amega BiotechLatest Information Update: 12 Jan 2022
Price :
$50
*
At a glance
- Originator Amega Biotech
- Class Antineoplastics; Antiretrovirals; Antivirals; Immunotherapies; Interferons; Polyethylene glycols; Skin disorder therapies
- Mechanism of Action Interferon alpha stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Hepatitis C
Most Recent Events
- 14 Aug 2013 Investigation in Hepatitis C in Argentina (Parenteral)